Skip to main content
. 2022 Mar 16;8(1):e002160. doi: 10.1136/rmdopen-2021-002160

Figure 3.

Figure 3

(A) Relapse-free survival and (B) overall survival probabilities for the 119 ANCA-MPO–positive granulomatosis with polyangiitis (GPA) patients versus 608 PR3-ANCA–positive and ANCA-negative GPA patients combined. ANCA, antineutrophil cytoplasm antibody; MPO, myeloperoxidase; PR3, proteinase-3.